文章摘要
杨洪屈园园马红艳普雄明胡凤侠.胸腺五肽联合干扰素治疗慢性湿疹的疗效观察[J].,2014,14(2):300-301
胸腺五肽联合干扰素治疗慢性湿疹的疗效观察
Clinical Observation on the Efficacy of Thymopoietin-5 and Interferon in theTreatment of Chronic Eczema
  
DOI:
中文关键词: 胸腺五肽  干扰素  慢性湿疹  疗效
英文关键词: Thymopoietin-5  Interferon  Chronic eczema  Efficacy
基金项目:
作者单位
杨洪屈园园马红艳普雄明胡凤侠 新疆自治区人民医院皮肤科 
摘要点击次数: 582
全文下载次数: 911
中文摘要:
      摘要目的:探讨胸腺五肽联合干扰素治疗慢性湿疹的临床效果及安全性。方法:随机将2009~2012 年我科收治的60 例慢性湿 疹患者分为两组,治疗组30 例在给予相应的抗组胺药、非特异性抗过敏治疗的基础上加用胸腺五肽针10 mg 与干扰素琢-2b 200 万U交替肌注,对照组30 例只给予抗组胺药、非特异性抗过敏治疗,两组均在3 周后观察其治疗效果及不良反应的发生情况。结 果:治疗三周后,治疗组总有效率为70%,对照组总有效率为33.33%,两组总有效率比较差异有统计学意义(P<0.05)。两组不良反 应的发生率比较并无统计学差异(P>0.05)。结论:胸腺五肽联合干扰素治疗慢性湿疹的临床疗效显著,副作用较小,安全性较高, 值得临床推广应用。
英文摘要:
      ABSTRACT Objective:To explore the clinical efficacy and safety of thymopoietin-5 combined with interferon in the treatment of chronic eczema. Methods:60 cases with chronic eczema hospitalized in our department from 2009 to 2012 were randomly divided into two groups, 30 cases in the treatment group were treated with antihistamines, non-specific anti-allergic therapy as well as alternating injection of thymopoietin-5 10mg/day and interferon α-2b 2× 106 U/day. 30 cases in the control group were only given antihistamines, non-specific anti-allergic therapy. The clinical efficacy and adverse effects were observed after three weeks.Results: Three weeks after treatment, the total effective rate of treatment group was 70%, which was significantly higher than that in the control group (33.33%, P< 0.05). No significant difference of incidence of adverse reactions was observed between the two groups (P>0.05).Conclusion: Thymopoietin-5 plus interferon was effective and safe in the treatment of chronic eczema, it was showed good efficacy with little adverse effect and worth being further widely popularized in clinic.
查看全文   查看/发表评论  下载PDF阅读器
关闭